Session 1: CDC Preparedness Update

Date: 2/24/2010 Check-In and Breakfast:
7:00 am - 8:00 am
Educational Session: 8:00 am - 1:00 pm

Susan E. Gorman, Pharm.D. M.S. DABAT Centers for Disease Control and Prevention (CDC)

Anita B. Patel, Pharm.D., M.S. Centers for Disease Control and Prevention (CDC)

Wayne D Williams, PharmD Executive Director for Coldchain Technology Services , Live CME Instructor for University Learning Systems
Susan E. Gorman, Pharm.D. M.S. DABAT Centers for Disease Control and Prevention (CDC)

Anita B. Patel, Pharm.D., M.S. Centers for Disease Control and Prevention (CDC)

Wayne D Williams, Executive Director for Coldchain Technology Services

Strategic National Stockpile:  Overview,  CHEMPACK Program, and Cities Readiness Initiative  (Susan Gorman)

  1. Describe the Strategic National Stockpile and when it is used
  2. List three ways the Strategic National Stockpile can respond to an event
  3. List six considerations for including an item in the Strategic National Stockpile
  4. Describe the CHEMPACK program and when it is used
  5. Describe the contents of the two types of CHEMPACK containers
  6. Describe the goal of the Cities Readiness Initiative
  7. List three state and local responsibilities in the Cities Readiness Initiative

Investigational New Drug (IND) Protocols and Emergency Use Authorization (EUA)  What it Means in a Public Health Disaster or Terrorist Event  (Anita Patel)

  1. Identify how IND and EUA apply to pharmaceuticals/countermeasures in the Strategic National Stockpile and in the community
  2. Describe the conditions that must be met for an EUA to be authorized by the Food and Drug Administration
  3. Identify the federal, state and local responsibilities for using countermeasures under an IND or EUA
  4. List an example of a countermeasure in the Strategic National Stockpile that must be used under IND or EUA

Pandemic Influenza Preparedness Update  (Anita Patel)

  1. Describe the current potential pandemic situation
  2. Describe the stockpiling efforts of the federal government
  3. Describe the decision making process to release antiviral drugs and other flu related countermeasures

Medical Waste: Laws and Regulations, and the Medical Waste Management System (MWMS) (Wayne Williams)

  1. Identify agencies responsible for regulating medical waste management
  2. List items considered regulated medical waste
  3. Identify the types of waste generated by the deployment of Strategic National Stockpile assets
  4. Define the MWMS™ purchased by the Strategic National Stockpile and how it supports the sustainment of the program
  5. Define the products and services being offered through the MWMS™

Deployment of the Medical Waste Management System (MWMS) (Wayne Williams)

  1. Describe the general considerations for staging and setup of the MWMSTM
  2. Differentiate the components of the medical waste management protocol
  3. Plan the arrangement of the MWMS components
  4. Specify the requirements for labeling and packaging medical waste
  5. Outline  packaging, labeling, and disposal of medical wastes
[an error occurred while processing this directive]